IBDEI06U ; ; 06-AUG-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 06, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8963,2)
 ;;=^7079
 ;;^UTILITY(U,$J,358.3,8964,0)
 ;;=282.9^^62^522^67
 ;;^UTILITY(U,$J,358.3,8964,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8964,1,4,0)
 ;;=4^282.9
 ;;^UTILITY(U,$J,358.3,8964,1,5,0)
 ;;=5^Hemolytic Anem, Heredit
 ;;^UTILITY(U,$J,358.3,8964,2)
 ;;=^56578
 ;;^UTILITY(U,$J,358.3,8965,0)
 ;;=283.19^^62^522^70
 ;;^UTILITY(U,$J,358.3,8965,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8965,1,4,0)
 ;;=4^283.19
 ;;^UTILITY(U,$J,358.3,8965,1,5,0)
 ;;=5^Hemolytic Anemia, Microang
 ;;^UTILITY(U,$J,358.3,8965,2)
 ;;=^293664
 ;;^UTILITY(U,$J,358.3,8966,0)
 ;;=280.9^^62^522^74
 ;;^UTILITY(U,$J,358.3,8966,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8966,1,4,0)
 ;;=4^280.9
 ;;^UTILITY(U,$J,358.3,8966,1,5,0)
 ;;=5^Iron Defic Anemia(Unspecified)
 ;;^UTILITY(U,$J,358.3,8966,2)
 ;;=^276946
 ;;^UTILITY(U,$J,358.3,8967,0)
 ;;=285.1^^62^522^72
 ;;^UTILITY(U,$J,358.3,8967,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8967,1,4,0)
 ;;=4^285.1
 ;;^UTILITY(U,$J,358.3,8967,1,5,0)
 ;;=5^Iron Defic Anemia Due To Acute Blood Loss
 ;;^UTILITY(U,$J,358.3,8967,2)
 ;;=^267986
 ;;^UTILITY(U,$J,358.3,8968,0)
 ;;=280.0^^62^522^73
 ;;^UTILITY(U,$J,358.3,8968,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8968,1,4,0)
 ;;=4^280.0
 ;;^UTILITY(U,$J,358.3,8968,1,5,0)
 ;;=5^Iron Defic Anemia Due To Chronic Blood Loss
 ;;^UTILITY(U,$J,358.3,8968,2)
 ;;=^267971
 ;;^UTILITY(U,$J,358.3,8969,0)
 ;;=281.9^^62^522^92
 ;;^UTILITY(U,$J,358.3,8969,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8969,1,4,0)
 ;;=4^281.9
 ;;^UTILITY(U,$J,358.3,8969,1,5,0)
 ;;=5^Nutritional Anemia
 ;;^UTILITY(U,$J,358.3,8969,2)
 ;;=^123801
 ;;^UTILITY(U,$J,358.3,8970,0)
 ;;=281.0^^62^522^109
 ;;^UTILITY(U,$J,358.3,8970,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8970,1,4,0)
 ;;=4^281.0
 ;;^UTILITY(U,$J,358.3,8970,1,5,0)
 ;;=5^Vit B12 Deficiency (Pernicious Anemia)
 ;;^UTILITY(U,$J,358.3,8970,2)
 ;;=^7161
 ;;^UTILITY(U,$J,358.3,8971,0)
 ;;=282.60^^62^522^99
 ;;^UTILITY(U,$J,358.3,8971,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8971,1,4,0)
 ;;=4^282.60
 ;;^UTILITY(U,$J,358.3,8971,1,5,0)
 ;;=5^Sickle-Cell Anemia
 ;;^UTILITY(U,$J,358.3,8971,2)
 ;;=^7188
 ;;^UTILITY(U,$J,358.3,8972,0)
 ;;=282.62^^62^522^100
 ;;^UTILITY(U,$J,358.3,8972,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8972,1,4,0)
 ;;=4^282.62
 ;;^UTILITY(U,$J,358.3,8972,1,5,0)
 ;;=5^Sickle-Cell With Crisis
 ;;^UTILITY(U,$J,358.3,8972,2)
 ;;=^267982
 ;;^UTILITY(U,$J,358.3,8973,0)
 ;;=281.1^^62^522^110
 ;;^UTILITY(U,$J,358.3,8973,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8973,1,4,0)
 ;;=4^281.1
 ;;^UTILITY(U,$J,358.3,8973,1,5,0)
 ;;=5^Vit B12 Deficiency(Dietary)
 ;;^UTILITY(U,$J,358.3,8973,2)
 ;;=^267974
 ;;^UTILITY(U,$J,358.3,8974,0)
 ;;=286.7^^62^522^44
 ;;^UTILITY(U,$J,358.3,8974,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8974,1,4,0)
 ;;=4^286.7
 ;;^UTILITY(U,$J,358.3,8974,1,5,0)
 ;;=5^Coagulation Defect(Any),Acquired
 ;;^UTILITY(U,$J,358.3,8974,2)
 ;;=^2235
 ;;^UTILITY(U,$J,358.3,8975,0)
 ;;=289.9^^62^522^106
 ;;^UTILITY(U,$J,358.3,8975,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8975,1,4,0)
 ;;=4^289.9
 ;;^UTILITY(U,$J,358.3,8975,1,5,0)
 ;;=5^Thrombocytosis, Essential
 ;;^UTILITY(U,$J,358.3,8975,2)
 ;;=^55344
 ;;^UTILITY(U,$J,358.3,8976,0)
 ;;=451.9^^62^522^107
 ;;^UTILITY(U,$J,358.3,8976,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8976,1,4,0)
 ;;=4^451.9
 ;;^UTILITY(U,$J,358.3,8976,1,5,0)
 ;;=5^Thrombophlebitis 
 ;;^UTILITY(U,$J,358.3,8976,2)
 ;;=^93357
 ;;^UTILITY(U,$J,358.3,8977,0)
 ;;=446.6^^62^522^108
 ;;^UTILITY(U,$J,358.3,8977,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8977,1,4,0)
 ;;=4^446.6
 ;;^UTILITY(U,$J,358.3,8977,1,5,0)
 ;;=5^Thrombotic Thrombocytopenic Purpura(Ttp)
 ;;^UTILITY(U,$J,358.3,8977,2)
 ;;=^119061
 ;;^UTILITY(U,$J,358.3,8978,0)
 ;;=286.4^^62^522^111
 ;;^UTILITY(U,$J,358.3,8978,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8978,1,4,0)
 ;;=4^286.4
 ;;^UTILITY(U,$J,358.3,8978,1,5,0)
 ;;=5^Von Willebrand'S Disease
 ;;^UTILITY(U,$J,358.3,8978,2)
 ;;=^127267
 ;;^UTILITY(U,$J,358.3,8979,0)
 ;;=204.00^^62^522^4
 ;;^UTILITY(U,$J,358.3,8979,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8979,1,4,0)
 ;;=4^204.00
 ;;^UTILITY(U,$J,358.3,8979,1,5,0)
 ;;=5^All, W/O Remission
 ;;^UTILITY(U,$J,358.3,8979,2)
 ;;=^267521
 ;;^UTILITY(U,$J,358.3,8980,0)
 ;;=204.01^^62^522^3
 ;;^UTILITY(U,$J,358.3,8980,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8980,1,4,0)
 ;;=4^204.01
 ;;^UTILITY(U,$J,358.3,8980,1,5,0)
 ;;=5^All, In Remission
 ;;^UTILITY(U,$J,358.3,8980,2)
 ;;=^267522
 ;;^UTILITY(U,$J,358.3,8981,0)
 ;;=204.10^^62^522^41
 ;;^UTILITY(U,$J,358.3,8981,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8981,1,4,0)
 ;;=4^204.10
 ;;^UTILITY(U,$J,358.3,8981,1,5,0)
 ;;=5^Cll, W/O Remission
 ;;^UTILITY(U,$J,358.3,8981,2)
 ;;=^267523
 ;;^UTILITY(U,$J,358.3,8982,0)
 ;;=204.11^^62^522^40
 ;;^UTILITY(U,$J,358.3,8982,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8982,1,4,0)
 ;;=4^204.11
 ;;^UTILITY(U,$J,358.3,8982,1,5,0)
 ;;=5^Cll, In Remission
 ;;^UTILITY(U,$J,358.3,8982,2)
 ;;=^267524
 ;;^UTILITY(U,$J,358.3,8983,0)
 ;;=201.90^^62^522^71
 ;;^UTILITY(U,$J,358.3,8983,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8983,1,4,0)
 ;;=4^201.90
 ;;^UTILITY(U,$J,358.3,8983,1,5,0)
 ;;=5^Hodgkin'S Lymphoma, Unpsec Type & Site
 ;;^UTILITY(U,$J,358.3,8983,2)
 ;;=^267430
 ;;^UTILITY(U,$J,358.3,8984,0)
 ;;=785.6^^62^522^77
 ;;^UTILITY(U,$J,358.3,8984,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8984,1,4,0)
 ;;=4^785.6
 ;;^UTILITY(U,$J,358.3,8984,1,5,0)
 ;;=5^Lymphadenopathy
 ;;^UTILITY(U,$J,358.3,8984,2)
 ;;=^72368
 ;;^UTILITY(U,$J,358.3,8985,0)
 ;;=200.20^^62^522^78
 ;;^UTILITY(U,$J,358.3,8985,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8985,1,4,0)
 ;;=4^200.20
 ;;^UTILITY(U,$J,358.3,8985,1,5,0)
 ;;=5^Lymphoma, Burkitt'S, Unspecified Sites
 ;;^UTILITY(U,$J,358.3,8985,2)
 ;;=^17529
 ;;^UTILITY(U,$J,358.3,8986,0)
 ;;=202.00^^62^522^80
 ;;^UTILITY(U,$J,358.3,8986,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8986,1,4,0)
 ;;=4^202.00
 ;;^UTILITY(U,$J,358.3,8986,1,5,0)
 ;;=5^Lymphoma, Low-Grade, Unspec Site
 ;;^UTILITY(U,$J,358.3,8986,2)
 ;;=^72606
 ;;^UTILITY(U,$J,358.3,8987,0)
 ;;=200.10^^62^522^79
 ;;^UTILITY(U,$J,358.3,8987,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8987,1,4,0)
 ;;=4^200.10
 ;;^UTILITY(U,$J,358.3,8987,1,5,0)
 ;;=5^Lymphoma, Int Or High Grade, Unspec Site
 ;;^UTILITY(U,$J,358.3,8987,2)
 ;;=^175886
 ;;^UTILITY(U,$J,358.3,8988,0)
 ;;=273.3^^62^522^81
 ;;^UTILITY(U,$J,358.3,8988,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8988,1,4,0)
 ;;=4^273.3
 ;;^UTILITY(U,$J,358.3,8988,1,5,0)
 ;;=5^Macroglobulinemia
 ;;^UTILITY(U,$J,358.3,8988,2)
 ;;=^73013
 ;;^UTILITY(U,$J,358.3,8989,0)
 ;;=203.00^^62^522^90
 ;;^UTILITY(U,$J,358.3,8989,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8989,1,4,0)
 ;;=4^203.00
 ;;^UTILITY(U,$J,358.3,8989,1,5,0)
 ;;=5^Multiple Myeloma W/O Rem
 ;;^UTILITY(U,$J,358.3,8989,2)
 ;;=^267514
 ;;^UTILITY(U,$J,358.3,8990,0)
 ;;=203.01^^62^522^89
 ;;^UTILITY(U,$J,358.3,8990,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8990,1,4,0)
 ;;=4^203.01
 ;;^UTILITY(U,$J,358.3,8990,1,5,0)
 ;;=5^Multiple Myeloma In Remission
 ;;^UTILITY(U,$J,358.3,8990,2)
 ;;=^267515
 ;;^UTILITY(U,$J,358.3,8991,0)
 ;;=238.6^^62^522^93
 ;;^UTILITY(U,$J,358.3,8991,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8991,1,4,0)
 ;;=4^238.6
 ;;^UTILITY(U,$J,358.3,8991,1,5,0)
 ;;=5^Plasmacytoma Nos
 ;;^UTILITY(U,$J,358.3,8991,2)
 ;;=^81973
 ;;^UTILITY(U,$J,358.3,8992,0)
 ;;=205.00^^62^522^6
 ;;^UTILITY(U,$J,358.3,8992,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8992,1,4,0)
 ;;=4^205.00
 ;;^UTILITY(U,$J,358.3,8992,1,5,0)
 ;;=5^Aml, W/O Remission
 ;;^UTILITY(U,$J,358.3,8992,2)
 ;;=^267531
 ;;^UTILITY(U,$J,358.3,8993,0)
 ;;=205.01^^62^522^5
 ;;^UTILITY(U,$J,358.3,8993,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8993,1,4,0)
 ;;=4^205.01
 ;;^UTILITY(U,$J,358.3,8993,1,5,0)
 ;;=5^Aml, In Remission
 ;;^UTILITY(U,$J,358.3,8993,2)
 ;;=^267532
 ;;^UTILITY(U,$J,358.3,8994,0)
 ;;=205.10^^62^522^43
 ;;^UTILITY(U,$J,358.3,8994,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8994,1,4,0)
 ;;=4^205.10
 ;;^UTILITY(U,$J,358.3,8994,1,5,0)
 ;;=5^Cml, W/O Remission
 ;;^UTILITY(U,$J,358.3,8994,2)
 ;;=^267533
 ;;^UTILITY(U,$J,358.3,8995,0)
 ;;=205.11^^62^522^42
 ;;^UTILITY(U,$J,358.3,8995,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8995,1,4,0)
 ;;=4^205.11
 ;;^UTILITY(U,$J,358.3,8995,1,5,0)
 ;;=5^Cml, In Remission
 ;;^UTILITY(U,$J,358.3,8995,2)
 ;;=^267534
 ;;^UTILITY(U,$J,358.3,8996,0)
 ;;=289.0^^62^522^45
 ;;^UTILITY(U,$J,358.3,8996,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8996,1,4,0)
 ;;=4^289.0
 ;;^UTILITY(U,$J,358.3,8996,1,5,0)
 ;;=5^Erthryocytosis, Secondary
 ;;^UTILITY(U,$J,358.3,8996,2)
 ;;=^186856
 ;;^UTILITY(U,$J,358.3,8997,0)
 ;;=238.4^^62^522^94
 ;;^UTILITY(U,$J,358.3,8997,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8997,1,4,0)
 ;;=4^238.4
 ;;^UTILITY(U,$J,358.3,8997,1,5,0)
 ;;=5^Polycytheria Rubra Vera
 ;;^UTILITY(U,$J,358.3,8997,2)
 ;;=^96105
 ;;^UTILITY(U,$J,358.3,8998,0)
 ;;=V58.61^^62^522^112
 ;;^UTILITY(U,$J,358.3,8998,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8998,1,4,0)
 ;;=4^V58.61
 ;;^UTILITY(U,$J,358.3,8998,1,5,0)
 ;;=5^Warfarin/Coumadin Use
 ;;^UTILITY(U,$J,358.3,8998,2)
 ;;=Warfarin/Coumadin Use^303459
 ;;^UTILITY(U,$J,358.3,8999,0)
 ;;=282.49^^62^522^104
 ;;^UTILITY(U,$J,358.3,8999,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,8999,1,4,0)
 ;;=4^282.49
 ;;^UTILITY(U,$J,358.3,8999,1,5,0)
 ;;=5^Thalassemia Nec
 ;;^UTILITY(U,$J,358.3,8999,2)
 ;;=^329910
 ;;^UTILITY(U,$J,358.3,9000,0)
 ;;=289.89^^62^522^13
 ;;^UTILITY(U,$J,358.3,9000,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9000,1,4,0)
 ;;=4^289.89
 ;;^UTILITY(U,$J,358.3,9000,1,5,0)
 ;;=5^Blood Diseases Nec
 ;;^UTILITY(U,$J,358.3,9000,2)
 ;;=^329887
 ;;^UTILITY(U,$J,358.3,9001,0)
 ;;=238.79^^62^522^76
 ;;^UTILITY(U,$J,358.3,9001,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9001,1,4,0)
 ;;=4^238.79
